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Abstract
The search for ideal implants or alternative scaffolds is a challenge for biomedical science 
researchers, especially in diabetic patients. Many alternative bioactive materials have 
been used in the regenerative medicine, especially in patient with complex metabolic 
disorder as diabetes mellitus. Among them, we discussed the following alternative mate-
rial scaffolds, including amniotic membrane (AM), homogenous demineralized dentin 
matrix (HDDM), platelet-rich plasma (PRP), and alloplastic materials as porous polyeth-
ylene and polyurethane. These biomaterials were applied in the craniomaxillofacial com-
plex and liver injury, resulting in tissue regeneration and microstructural reconstruction 
due to their effective inductive and conductive properties. Additionally, diabetes disease 
and its general biophysical mechanism and systemic complications were described in 
order to improve the comprehension of the physiopathology of this comorbidity and its 
effects in the tissues. The AM, HDDM, and PRP in implantation sites initiated an induc-
tive cascade as chemotaxis of progenitor cells, mitogenesis, angiogenesis, and differentia-
tion into wide variety of cells. The cell recruitment, division rate, and differentiation of 
cell lines are under the direct control of several growth factors and stem cells which are 
present in these biomaterials. Further, some alloplastic materials have triggered satisfac-
tory tissue responses when used in treatments of craniofacial deformities or in anatomi-
cal reconstructions.
Keywords: regenerative medicine, amniotic membrane, homogenous dentin demineralized 
matrix, platelet-rich plasma, alloplastic material, diabetes mellitus
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1. Introduction
Diabetes mellitus (DM), a complex metabolic disorder, is a syndrome characterized by abnor-
malities in carbohydrate, lipid, and protein metabolism, which results either from a partial or an 
absolute insulin deficiency or from target tissue resistance to its cellular metabolic effects. This 
disease is characterized by the presence of few or by the absence of functional pancreatic β-cells 
in the islets of Langerhans and by a substantial reduction or inexistence of insulin secretion. 
This cellular dysfunction is an important defect in the pathogenesis of type 2 diabetes [1, 29].
Many strategies have been used as a biological dressing, an alternative bioactive material 
scaffold, and alloplastic material, including amniotic membrane (AM), demineralized dentin 
matrix (DDM), platelet-rich plasma (PRP), and alloplastic materials as porous polyethylene 
(porous PTFE) implant, in the degenerative complications in the diabetes disease. The AM 
is a high-throughput source for multipotent mesenchymal stem cells (MSCs) with the abil-
ity to differentiate into wide variety of cells, such as chondroblasts, osteoblasts, adipocytes 
and fibroblasts, myocytes, endothelial cells, neuronal cells, and hepatocytes, leading to forma-
tion of cartilage, bone, connective, muscle, blood vessel, nerve, and liver tissues, respectively. 
This membrane acts as a barrier prevents the entry of pathogens and toxins, preserves tissue 
structure, and consequently reduces the levels of local pro-inflammatory cytokines. The DDM 
is a bioactive tissue able to stimulate the bone repair process, to increase bone mass, and to 
improve bone microstructure without causing any rejection or infection. It is noteworthy that 
it acts as a reservoir for various proteins that are embedded within the matrix and are available 
to local cells, including bone morphogenetic proteins (BMPs), insulin-like growth factors I and 
II (IGF I and IGF II), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), 
transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF).
Based on the literature, we consider that the rich AM and DDM biological properties could 
be associated with other traditional graft materials, improving their biodynamic effects when 
implanted in host sites. Some alloplastic materials are well tolerated by the host tissues and 
present good stability in the implementation site, including porous polyethylene and poly-
urethane. These materials have been used in orthopedic, articular, orbital, cranial, and maxil-
lofacial reconstruction. The presence of porous allows the ingrowth of the host tissue, which 
promotes better anchorage of the polymers in the host tissue.
Therefore, these alternative therapies may provide beneficial effects on tissue regeneration 
and reconstruction, in particular, in diabetes, since one of the main complications is delayed 
and abnormal repair process by accumulation of advanced glycation endproducts (AGEs) on 
tissues. These products cause severe widespread damage to tissue through upregulation of 
inflammation and cross linking of collagen and other proteins.
2. Diabetes mellitus
Diabetes mellitus is known as a metabolic disorder, characterized by deficiency of insulin 
secretion or action, leading to chronic hyperglycemia and disturbances of carbohydrate, fat, 
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and protein metabolism, may develop in, called diabetes mellitus (DM). According to the 
International Diabetes Federation, 8.8% of the adult population worldwide has diabetes. Of 
all individuals with diabetes, only 10–15% have type 1 diabetes mellitus (T1DM); type 2 dia-
betes mellitus (T2DM) is the most common form. However, T1DM is the most common form 
of diabetes in children (<15 years of age), and >500,000 children are currently living with this 
condition globally. The classification of diabetes mellitus disease defines both process and 
stage of the disease. The processes include type 1, autoimmune and nonautoimmune, with 
beta-cell destruction; type 2 with varying degrees of insulin resistance and insulin hyposecre-
tion; gestational diabetes mellitus; and other types where the cause is known [1].
3. Development of the diabetes disease
Alterations in the molecular mechanisms of via insulin signaling may provide a deficiency, 
resistance, and/or decrease of insulin release into bloodstream, leading to development of the 
diabetes mellitus. To improve the comprehension of the physiopathology of this comorbid-
ity and its effects in the tissues, firstly, it is important to know the biophysical mechanism 
involved in the glucose transport and the mechanism of insulin release, as well as the relation-
ship of the glycation and diabetic complications.
3.1. Biophysical mechanism involved in the glucose transport
Fasting blood glucose levels are between 70 and 99 mg/dL in healthy individuals. These values 
can vary depending on food intake, renal function, physical activity, and the method used 
for testing. The major dietary polysaccharides, also called carbohydrates, for many species 
are starch and glycogen which are a storage form of glucose arisen from plants and animals, 
respectively. After food intake, the digestion process of vegetable (starch) and animal (glyco-
gen) polysaccharides initiates from mouth, which are broken down by the salivary amylase 
(ptyalin), leading to the formation of oligosaccharides. Afterward, pancreatic and digestive 
enzymes break down these macromolecules to monosaccharides (glucose, fructose, and galac-
tose) from upper small intestine. Posteriorly, these monosaccharides enter into enterocytes by 
luminal membrane transporters. It is worth highlighting that the pancreatic amylase is pro-
duced by the pancreatic acinar tissue, while the maltase, isomaltase, saccharase, and lactase are 
generated by the enterocytes. Pancreas is known as a glandular organ in the upper abdomen, 
which serves as two glands in one: a digestive exocrine gland (e.g., production of pancreatic 
amylase) and a hormone-producing endocrine gland especially composed of islets Langerhans. 
These islets are constituted of four hormone-producing cell types: insulin-secreting beta cells, 
glucagon-secreting alpha cells, somatostatin-secreting delta cells, and pancreatic, polypeptide-
secreting F cells. Both the glands are vital to the body’s survival (Figure 1).
Several factors can influence in the insulin secretion, including amino acids, fatty acids, hor-
mones, and drugs; however, the blood glucose concentration levels are considered the main 
physiological regulators of insulin release. The glucose molecule (C
6
H12O6) depends on a transporter protein to enter the cells, seeing that is impermeable to cell membrane. Thus, the 
glucose uptake from intestinal lumen occurs through ion-coupled membrane cotransporters 
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which are molecular machines that use the electrochemical energy of a transmembrane ionic 
gradient to energize the transport of another solute [37]. Among them, it is known as the type 
1 sodium-glucose cotransporter (SGLT-1) that is located at the cell membrane of the apical 
region of the enterocytes. This cotransporter is coded by the SLC5A1 gene, which was the first 
mammalian cotransporter carrier protein to be identified, cloned, and sequenced [4].
The present review discusses the members of the sodium-glucose cotransporter (SGLT) gene 
family (the SLC5A gene family) have been identified in a broad range of tissues, including 
intestine, kidney, muscle, neurons, and thyroid [21, 36]. The SGLT-1 protein has two allo-
steric sites that carry a galactose or glucose molecule and sodium ions (2Na+) into the cells, 
while fructose molecule passes across the luminal membrane through the GLUT-5 (fructose 
transporter). Both the transport proteins are found at the apical surface of the enterocytes 
in the small intestine [9]. The glucose transporters (GLUTs) are sodium-independent mem-
brane transport proteins which carry particularly monosaccharides, including glucose fruc-
tose and galactose. Various members of solute-carrier (SLC) gene family have been found in 
Figure 1. Diagram showing carbohydrate degradation by oral, pancreatic, and intestinal enzymes.
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literature [28]. None of these transport mechanisms requires cell energy expenditure, char-
acterizing a biological process of passive transport.
Considering the intestinal epithelial cells, the glucose entry depends on the electrochemi-
cal gradient of Na+, as well as its translocation from luminal membrane to basolateral mem-
brane. These differences of extracellular and intracellular concentrations of Na+ are kept by 
the sodium-potassium pump. The potassium ions (K+) into cells pass to extracellular matrix 
(ECM) through specific channels, located at the basal membrane that maintains pump activ-
ity. The sodium-potassium pump is an active transport mechanism which requires energy 
expenditure using adenosine triphosphate (ATP). The internal cell membrane potential of 
the enterocytes is negative in relation to the external cell membrane, typically about −70 mil-
livolts. This voltage arises from differences in concentration of the sodium and potassium 
electrolyte ions, leading to glucose entry into cells. The glucose molecule passes into the extra-
cellular matrix (ECM) through the glucose transporter-2 protein (GLUT-2). Then, it enters in 
the bloodstream due to the differences of gradient concentration between the ECM and blood 
capillary (Figure 2). Considering the biological property of the blood vessels, intercellular 
clefts, fenestrations, and cell membrane discontinuity of the endothelial cells also facilitate the 
gradient diffusion into bloodstream [24].
3.2. Mechanism of insulin release
As previous discussion, the elevated levels of blood glucose generate insulin release from 
pancreatic β-cells at the islets Langerhans, which plays a pivotal role in the glucose homeosta-
sis and acts in a coordinated fashion on cellular events that regulate the metabolic and growth 
processes in the human body.
Figure 2. Diagram showing the glucose absorption by the enterocytes.
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In humans, the threshold value for glucose-stimulated insulin secretion is about 100 mg/dL 
(5.6 mmol/L) of plasma glucose concentration. This hormone is secreted in a biphasic manner 
in response to a marked increase in blood glucose. An initial burst of insulin secretion may 
last 5 to 15 min, resulting from the secretion of preformed insulin secretory granules. This 
response is followed by more gradual and sustained insulin secretion that results largely from 
the synthesis of new insulin molecules.
The primary mechanism is through binding to sulfonylurea receptor (SUR-1) on function-
ing pancreatic β-cells. Afterward, binding closes the linked ATP-sensitive potassium channels 
(KATP channels), which leads to decreased potassium influx and subsequent depolarization of the β-cell membrane. This event provides voltage-dependent T-type calcium (Ca2+) and 
sodium (Na+) channel opening, resulting in an influx of Ca+ channel, as a consequence, caus-
ing translocation and exocytosis of insulin-secretory granules to the cell surface. Then, the 
insulin from the ECM enters into the bloodstream, following toward the target cells [5].
Another mechanism that promotes ATP-sensitive potassium channel closure is increased ATP 
levels, which are produced into two distinct metabolic pathways: glycolysis (anaerobic pro-
cess) and mitochondrial respiratory chain (aerobic process). Initially, the glucose molecule 
passes across the β-cell membrane through the glucose transporter 2 (GLUT-2), and then, it is 
phosphorylated to form glucose-6-phospate (G-6-P) by two enzymes: hexokinase IV (HK-IV) 
or glucokinase (GK) of lower affinity for glucose and hexokinase I (HK-I) of higher affinity 
for glucose. However, the higher affinity enzyme is strongly inhibited by the G-6-P, transfer-
ring to the GK a key role in the glucose phosphorylation at the pancreatic β-cells. This pro-
cess constitutes the first flux determining step for glycolysis. The G6P is broken down into 
2-phosphoenolpyruvate by the pyruvate kinase which is transformed in two pyruvates mol-
ecules (glycolysis). After that, these molecules enter into mitochondria where two different 
biochemical processes occur, including the cycle of Krebs and the oxidative phosphorylation 
cycle. Finally, several ATP molecules are generated. The glycolysis and mitochondrial respira-
tory chain pathways result in the synthesis of 2 ATPs and 34–36 ATP molecules, respectively, 
totalizing about 36–38 ATP molecules/mol of glucose [5, 34]. It is noteworthy to highlight 
the promotor mechanisms to KATP channels closure lead to the insulin release into the blood stream (Figure 3).
After the insulin arrival onto target cells, it links to a specific cell membrane receptor, called 
insulin receptor substrate (IRS-1) protein, initiating a cascade of phosphorylation events. As a 
consequence, vesicles containing glucose transporter proteins, especially the GLUT-4, move 
to the cell surface. The high GLUT-4 level onto cell membrane leads to increase of glucose 
uptake. Depending on the cell activity, two processes can occur due to high concentration 
of intracellular glucose: glycolysis or glycogen synthesis. To elucidate better this mecha-
nism, GLUT-4 is an insulin-stimulated glucose transporter that has the primary form of the 
transporter present in skeletal muscle tissue and adipose tissue. It is present in cells and in 
intracellular vesicles of the smooth ER. In target cells, the effect of insulin is to promote the 
translocation of GLUT-4 transporter from intracellular pool to cell membranes. As a result, 
more transporters are available in the plasma membrane, and glucose uptake by target cells 
is, thereby, increased.
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Based on these basic concepts, we can consider that methods for SGLT and GLUT inhibition 
can be considered an suitable alternative means of managing glucose control and, as a conse-
quence, a further treatment option to control the diabetes disease.
3.3. Relationship of the glycation process and diabetic complications
Persistently elevated glucose levels during long-standing diabetes induce structural and func-
tional changes in various proteins in the body, including plasma protein (albumin, globulins, 
and fibrinogen) and collagens, through a glycation or nonenzymatic glycosylation process 
[3, 23, 39, 44]. This process involves an excessive chemical attachment of sugar molecule 
(e.g., glucose or fructose) to proteins, lipids, and nucleic acids, without the involvement of 
enzymes. Various deleterious effects from glycation of plasma protein may be produced, 
including alteration in drug binding in the plasma, platelet activation, generation of oxygen 
free radicals, impaired fibrinolysis, and impairment in immune system regulation. On the 
other hand, the structural impairment in collagen alters the osteoblast differentiation, leading 
Figure 3. Mechanism of insulin release from pancreatic β-cell to bloodstream.
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to disorders of bone remodeling process and, as a consequence, skeletal fragility [20, 39]. The 
glycation and oxidation of lipids and nucleotides can also form a single product from vari-
ous heterogeneous molecules (heterogeneous adducts) through amino-carbonyl reactions, 
known as advanced glycation endproducts (AGEs) [23, 27]. As the direct products of diabetic 
metabolic remodeling, AGEs are an important environmental medium for changes of cells, 
cytokines, and extracellular matrix components including collagens, proteoglycans, laminin, 
and vitronectin [11, 20]. These changes in the extracellular matrix cause specific alterations in 
bone formation and bone remodeling. Bone tissue turnover has been shown to be suppressed; 
studies have shown decreases in the percentage of osteoclasts and osteoblasts as well as a 
decrease in osteocalcin synthesis [8, 11, 16]. Moreover, AGEs exhibit the ability to inhibit cel-
lular differentiation, proliferation, and migration, which could delay the repair process [20].
Therefore, the protein glycation, elevated level of AGEs accumulation in tissue collagen, 
and high plasma AGE concentration lead to major diabetic complications like retinopathy, 
nephropathy, neuropathy, atherosclerosis, degenerative and cardiovascular diseases, inflam-
matory arthritis, osteoporosis, susceptibility to infections, delayed tissue repair, and severe 
periodontal disease [3, 17, 39]. Other generic complications are impaired neovascularization 
and microvascular complications, resulting in ulcers and chronic nonhealing wounds with 
the characteristics of high amputation rate [20, 46].
Currently, the major concerns with the use of AGEs inhibitors as therapeutic agents are low 
effectiveness, poor pharmacokinetics, and undesirable side effects. Several AGEs inhibitors 
possess potent antiglycation activity and are devoid of undesirable side effects. These small 
molecules inhibitors can, therefore, serve as scaffolds for the development and designing of 
new AGEs inhibitors as clinical agents [23].
Studies have described that high levels of AGEs induce increased index values of oxidative 
stress in bone cells due to the absence of the counterbalancing effects of endogenous antioxi-
dants [17]. Thus, it is considered that bone loss can occur as a result of activated osteoclasto-
genesis, attenuated osteoblastogenesis, and/or stimulated osteoblast apoptosis, which can be 
induced by the elevated intracellular levels of reactive oxygen species (ROSs) [13, 17]. ROSs 
produced either endogenously or exogenously are often associated with the principle of oxi-
dative stress, which can attack lipids, proteins, and nucleic acids simultaneously in living cells 
[45]. This free radical or byproducts of an aerobic metabolism, including superoxide anion 
(O2−), hydrogen peroxide (H2O2), and hydroxyl radicals (OH), can confer reactivity to differ-ent biological targets. Increasing evidences have suggested that oxidative stress plays a major 
role in the pathogenesis of diabetes mellitus due to structural and/or functional damage of 
the pancreatic β cells [38, 45]. Some studies have described that the persistent hyperglycemia 
has reduced recruitment of mesenchymal stem cells (MSCs) toward the wounds, compro-
mised their cellular differentiation, and affected the quantity of endothelial progenitor cells, 
preventing vasculogenesis and delaying the healing process [46]. Accumulating evidence also 
suggests that the impaired MSCs can compromise mobilization and function of bone cells, 
resulting in low bone turnover and formation [17].
Recently, alternative material scaffolds have been used to accelerate tissue repair process or 
to promote implant-based tissue reconstruction, besides the advent of stem cell therapy as a 
pivotal basis of tissue regeneration or replacing, bringing great hope to diabetic patients.
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4. Biological and alloplastic materials for tissue engineering
The goal of tissue engineering is to create grafts that enhance tissue repair following trauma, 
infection, or neoplasm, and for developmental abnormalities; these procedures represent a 
challenge in surgery. To obtain effective and suitable tissue regeneration or osseointegration, 
the following are necessary: osteoprogenitor and osteoconductive cells, which offer potential 
to differentiate and facilitate the various stages of tissue regeneration, growth factors (GFs), 
and structural integrity with the absence of any kind of local infection [17].
As a compensatory factor, some biomaterials for tissue engineering with promotive proper-
ties, including amniotic membrane (AM), demineralized dentin matrix (DDM), platelet-rich 
plasma (PRP), and porous polyethylene (porous PTFE) in diabetic and nondiabetics experi-
mental model were described as follows.
4.1. Diabetic experimental models
The main drugs widely used to induce diabetic experimental models are streptozotocin 
and alloxan. The cytotoxic action of both the diabetogenic agents is mediated by reactive 
oxygen species (ROS). The streptozotocin drug enters into pancreatic β-cells via a glucose 
transporter (GLUT-2) and causes alkylation of DNA. DNA damage induces activation of 
polyADP-ribosylation that leads to depletion of cellular NAD+ and ATP. Enhanced ATP 
dephosphorylation supplies a substrate for xanthine oxidase, resulting in the formation 
of superoxide radicals as hydrogen peroxide and hydroxyl radicals. Furthermore, toxic 
amounts of nitric oxide are release, causing inhibition of mitochondrial aconitase activity 
and DNA damage and triggering the destruction and necrosis of these cells. The alloxan 
drug promotes the superoxide radical formation, which undergoes the dismutation to 
hydrogen peroxide. Thereafter, highly reactive hydroxyl radicals are formed by the Fenton 
reaction. The ROS action and the simultaneous massive increase of cytosolic calcium con-
centration cause a rapid destruction of the pancreatic β-cells [41].
Experimental models for monohydrate alloxan-induced diabetes in rabbits and rats were 
developed. The diabetes was diagnosed due to the blood glucose levels above 200 mg/dL 
(Figure 4). This drug, in particular, promotes destruction of the pancreatic β-cells and paren-
chyma disorganization with presence of atypical acinar cells, scarce secretion vesicles, atro-
phy, and a decreased number of Langerhans islets in some regions, leading to severe pancreas 
dysfunction and, as a consequence, the development of diabetes type 2. Three months after 
the diagnosis of diabetes in experimental models, general clinical complications can be found, 
including weight loss, polyuria, polyphagia, ketoacidosis due to accentuated hypoglycemia, 
convulsions, diabetic foot, acute dermatitis, erythematous, and ulcerated lesion associated 
with fungal and bacterial infections located in the submandibular region extending to trunk 
and neck regions, and intracranial abscess in regions of surgical defect due to impaired 
bone repair and susceptibility to infections. Severe chronic gingivitis can be also evidenced 
(Figure 4) [11, 13, 42].
It is important to consider that diabetic wounds exhibit impaired angiogenesis, reduced 
growth factor levels, and reduced chemotactic ability to recruit inflammatory cells to the 
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wound, besides that the poor vascularization and maintenance of a chronic inflammatory 
state limit the healing capacity. Therefore, we discuss in this chapter some conductive and 
inductive materials for tissue engineering, including AM, DDM, PRP, and porous PTFE, 
which were applied in diabetic and nondiabetic experimental models or individuals.
4.2. Biological materials
4.2.1. Amniotic membrane (AM)
The AM is a tissue of fetal origin and is composed of three major layers: a single epithe-
lial layer, a thick basement membrane, and an avascular mesenchyme that contain growth 
factors, cytokines, and other active substances [26]. AM has two types of cells of different 
embryological origins: amnion epithelial cells derived from embryonic ectoderm and amnion 
mesenchymal cells from embryonic mesoderm. It is adjacent to the trophoblast cells and lines 
the amniotic cavity. It can be easily separated from the underlying chorion, with which it 
never truly fuses at the cellular level. Its nutrition and oxygen are obtained from surround-
ing chorionic fluid, the amniotic fluid, and the fetal surface vessels. This structure protects 
the developing embryo against mechanical aggression, provides an environment where the 
embryo can grow without distortion by pressure from surrounding structures, and also plays 
an important role during parturition [15].
As a highlight of great potential for clinical application, the amniotic membrane has been 
widely used in regenerative medicine due to its effective biological properties (biocompatibil-
ity, low immunogenicity, anti-inflammatory, and antimicrobial activities), adequate physi-
comechanical action (permeability, stability, elasticity, flexibility, and resorbability), excellent 
tissue adhesion, easy delivery of biomodulatory agents including growth factors and genetic 
materials, and rich MSC source [22, 31, 33]. Current investigations described that pluripotent 
stem cell lines derived from AM have the ability to differentiate into endothelial and neu-
ronal cells, osteogenic, chondrogenic, adipogenic, skeletal myogenic, hepatic lineages, and 
able suppress T-cell proliferation [19, 31, 35]. These properties show the greatest prospects 
Figure 4. Classical clinical complications in diabetes showing diabetic foot and chronic gingivitis (arrows) in rabbit after 
3 months persistent hyperglycemia.
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to clinical applications in regenerative medicine, which leads to processes of tissue replacing, 
engineering or regenerating, and preservation of organ functions [12, 26, 43].
Several researches developed in the Center of Biosciences Applied to Persons with Special 
Care Needs (CEBAPE) in the São Paulo State University (UNESP) has applied the AM as a 
biologic dressing and a bioactive scaffold material to treat oral mucositis, surgical hepatic 
resection areas in experiments in vivo, and wound areas from incisional and excisional biop-
sies of oral lesions originated of inflammatory and development processes. This membrane 
was also applied to stimulate the guided bone regeneration (GBR) in experimental bone 
defects and to accelerate the tissue repair.
The methods of preparation and storage of the human (h) and homogenous (H) AM were 
developed by the CEBAPE which are described in the literature [15, 18, 26, 43]. Additionally, 
the clinical procedures were performed in diabetic and nondiabetic patients or in different 
animal models, leading to highly favorable results that are reported as follows. We can prove 
its effects on the tissues through the clinical, biochemical, histological and immunohistochem-
ical outcomes, in particular, in experimental models. As a xenogenic material, a human amni-
otic membrane (hAM) was used for guided bone regenerative on surgical defects in healthy 
rabbits. The biocompatibility and low immunogenicity of the hAM were shown since we 
evidenced newly formed bone tissue in intimate contact with hAM in several surgical defect 
areas and discrete infiltration of mononuclear inflammatory cells surrounding  the hAM in 
some regions; moreover, its osteogenic and mitogenic effects were very evident (Figure 5).
Other application could be in oral biopsy areas to lesion diagnosis, especially in areas of dif-
ficult suture as alveolar bone ridge in maxilla and mandible. Studies also showed the use of 
hAM on wounds produced from incisional and excisional biopsies of alveolar gingiva of the 
upper premolar region and cheek mucosa, respectively. The diagnosis was plan lichen (inflam-
matory process) in the alveolar gingiva and intramucosal pigmented nevus (development pro-
cess). The outcomes were highly satisfactory in both processes, inducing the rapid closure of 
Figure 5. Human amniotic membrane (arrow-head) used as a bioactive xenogenic material which was applied in the 
guided bone regeneration on the surgical defect in rabbits: newly formed bone formation from the membrane and few 
infiltrations of mononuclear inflammatory cells, especially lymphocytes, were evidenced (Source: Gomes et al., [15]).
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wounds due to stimulation of the tissue repair, relief of pain, and no sign of local infection [18]. 
Probably, relief of pain occurs due to its strong action of mechanism barrier and good stability 
on the wound surface, covering nerve endings.
In previous research using homogenous amniotic membrane (HAM) on the surface of surgi-
cal liver, resection in rats was performed. The HAM was obtained female rats by cesarean 
at the 20th day of pregnancy. Fetal amniotic membrane was separated aseptically from the 
chorionic membrane and rinsed several times in a sterile physiological saline solution and 
a phosphate buffer at pH 7.4 until the removal of all debris (Figure 6). After its laboratory 
preparation, the HAM was placed on the surface of surgical liver resection. Clinically, this 
membrane showed an immediate stability and a strong hemostatic action after its implan-
tation on the wound. Histologically, the HAM behavior was observed in 10, 20, 30, and 40 
days, showing the following results. Initially, the HAM was biocompatible to hepatic tissue 
once it intimately adhered to hepatic tissue in regenerative process; subsequently, it under-
went metaplasia turning into a highly well-cellularized and vascularized tissue called amino-
hepatic tissue. Discrete infiltration of mononuclear inflammatory cells was seen surrounding 
this biological membrane. This histological characteristic was one of the prominent aspects 
that can suggest its low immunogenicity in surgically impaired liver tissue. HAM remnants 
can be found on the injured liver tissue surface in some specimens, after 40-day postsurgery 
(Figure 7). In biochemical analysis of plasma and tissue samples, the aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (GGT) enzy-
matic levels were significantly low; in contrast, the alkaline phosphatase (ALP) enzymatic 
levels and the total protein concentrations were strongly high in the rats treated with HAM. 
Thus, angiogenic, mitogenic, and hepatic-protector effects of the HAM were proved, leading 
to a better microstructural reconstruction of the injured liver [12].
In our study, other beneficial application of the HAM was as a potent biological dressing in 
5-fluorouracil-induced oral mucosites (OM) in rats (Figure 8). The pathophysiology of the ana-
lyzed OM and its histomorphological features were divided into four phases: inflammation (3 
days), cell proliferation (7 days), tissue organization (14 days), and tissue repair (21 days). Among 
the periods of inflammation and cell proliferation phases, the HAM was incorporated with the 
wound surface, acting as a protective barrier against microbial infection and preventing any 
infection signs. Other aspects were discrete to moderate infiltration of inflammatory cells in the 
connective tissue and early total re-epithelialization in most specimens. The incorporated HAM 
into connective tissue was degraded and, then resorbed. Regarding the tissue organization and 
repair phases, the histological features were described the follow. At 14 days, discrete mono-
nuclear inflammatory cells surrounding the connective tissue, muscle layer with normal aspect, 
a tissue maturation with regularly disposed, remodeled collagen fibers, and rare blood vessels 
were found. Finally, at 21 days, the oral mucosa showed normal aspects (Figure 9). Thus, we can 
consider that the HAM provides an excellent environment for cell proliferation and neovascular-
ization, stimulating healing process and functioning as a promising biological dressing. Previous 
studies confirm the growth factors are found into amniotic membrane, including transform-
ing growth factor-β1 and β2 (TGF-β1 and β2), basic fibroblast growth factor (bFGF), epidermal 
growth factor (EGF), transforming growth factor-α (TGF-α), keratinocyte growth factor (KGF), 
and hepatocyte growth factor (HGF) [33], reinforcing our findings. Regarding the biodegradable 
property of the HAM, we hypothesize that the avascular stromal matrix of the HAM is similar 
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extracellular matrix of the connective tissue in the submucosa region, favoring its degradation 
during the healing dynamic processes. Investigations report the AM presence of fibronectin, elas-
tin, nidogen, collagen types I, III, IV, V, and VI, elastin, and hyaluronic acid [31, 33].
4.2.2. Homogenous demineralized dentin matrix (HDDM)
Homogenous demineralized dentin matrix (HDDM) arises from tooth structure which has 
been widely used to stimulate bone regeneration, inducing osteoblastic differentiation and 
proliferation and chemotaxis. Hence, HDDM accelerates the bone repair process, increases 
bone mass, and improves bone quality without causing any rejection or infection. HDDM 
Figure 6. (a) Fetus, amniotic, and chorionic membrane (arrow) and (b) fresh HAM separated from the chorionic 
membrane and placed in sterile physiological saline solution and phosphate buffer at pH 7.4.
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slices comprise an extracellular matrix rich in collagen, without vessels, and act as a res-
ervoir for various proteins that are embedded within the matrix and are available to local 
cells. Regarding its main property, it is proved that the osteoinductive cascade begins with 
chemotaxis of bone progenitor cells, mitogenesis, angiogenesis, and bone cell differentiation. 
The cell recruitment, division rate, and differentiation of these cell lines are under the direct 
Figure 7. HAM placed on the surgically induced liver wound, HAM intimately adhered to the surface of the injured liver 
tissue and underwent metaplasia turning into amnion-hepatic tissue in 10 days post-surgery, and remnants of HAM on 
liver surface in the final step of the liver tissue regeneration in 40 days post-surgery. (hematoxylin-eosin, magnification ×25).
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control of HDDM growth factors, including BMPs [11, 14, 15]. Others growth factors include 
TGF-β, IGF I and IGF II, PDGF, FGF, TGF-β, and VEGF [17].
HDDM slices strongly favor the chemotaxis of appropriate cells into the surgical defect, the 
transformation of undifferentiated mesenchymal cells into osteoprogenitor cells, osteoblast pro-
liferation and differentiation, and the synthesis of the extracellular matrix with mineralization 
of osteoid tissue that leads to accelerated bone maturation and remodeling. It is worth highlight-
ing that the HDDM slices initially yielded hemostatic effects by mechanical action after their 
implantation in the periphery of the defect. Furthermore, it was demonstrated that the HDDM 
was incorporated into the newly formed bone matrix and resorbed during the bone remodeling 
process. Moreover, numerous osteoblasts and osteoprogenitor cells were also located adjacent 
to the HDDM, confirming its strong chemotactic activity. Studies suggested that HDDM pro-
vides bioactive molecules for the host of proteins and growth factors can be released through 
dentin matrix degradation and exposed dentinal tubules when HDDM is used in the form of 
slices [6, 11, 14, 15, 17]. Furthermore, when this biomaterial is used in the periphery of surgi-
cal defect, it is able to stimulate the reconstruction of the bone architectural microstructure, 
Figure 8. Oral mucositis in labial fornix region of inferior incisors (a), HAM placed on the wound (b), and normal oral 
mucosa surface after 7 days of treatment with HAM (c).
Figure 9. 5-Fluorouracil-induced oral mucosites. Histomorphological features divided into four phases: (a) inflammation 
(3 days), (b) cell proliferation (7 days), (c) tissue organization (14 days), and (d) tissue repair (21 days). Asterisk: HAM 
remnants incorporated into connective tissue in the submucosa region (proliferation phase) (hematoxylin-eosin, 
magnification ×25).
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 resulting in  formation of mature bone trabeculae and bone marrow. Initially, bone trabeculae 
were mature at the periphery and immature at the centre of the bone defect; thus, centripetal 
bone growth was seen in the bone repair process (Figures 10, 11). Finally, an exophytic bone 
growth can be evidenced due to the highest chemotactic, mitogenic, and osteogenic potential of 
the HDDM. Dependent of the animal’s age, a physiological conversion from red to yellow bone 
marrow can be observed, leading to large and regular medullary spaces (Figure 12).
Concerning the evidence of HDDM biocompatibility, two hypotheses are suggested by the 
present study. First, cell surface histocompatibility antigens and sequestered antigens are 
absent; however, they may be present throughout the extension of the remnant odontoblastic 
processes within the HDDM. Second, the decalcification process for teeth could cause the 
denaturation of surface proteins on the plasma membrane of the odontoblastic processes. It 
was considered that the plasma membrane of the odontoblastic processes could present not 
only cell surface histocompatibility antigens, but also sequestered antigens that, when not 
exposed to the cells of the immune system, do not trigger immunological reactions.
The resorption process of the HDDM slices presented the following phases: (1) the dentin 
matrix was first incorporated into the newly formed bone tissue; (2) next, the dentin was 
degraded during bone remodeling; and (3) the area in which the dentin matrix was located 
was replaced by new bone tissue (Figure 13).
Therefore, the HDDM could be considered as an ideal bone graft material since it stimulates osteo-
blast differentiation and proliferation and potentially leads to efficient bone regeneration. We sug-
gested that it could be used as a scaffold for stem cells and bone growth factors, since its biological 
properties have shown an excellent bioactive material for bone tissue engineering in diabetes.
Autogenous demineralized dentin matrix (ADDM) has been used to accelerate the dental socket 
wound healing process in humans. The ADDM is considerate biocompatible with surgical 
human dental sockets. Initially, radiopaque image suggestive of remaining ADDM slices can be 
found. Moreover, the radiographic bone density of the dental sockets treated with ADDM was 
similar to that of the surrounding normal bone from 90th day. It is worth highlighting that alve-
olar bone architecture is improved when the ADDM is used as an engineering tissue (Figure 14).
Figure 10. Clinical and radiographic images of surgical defect in the parietal bone of diabetic rabbits taken at 15 days. 
HDDM slices promoting hemostatic effects by mechanical action after their implantation and their osteogenic activity 
after 15 days in diabetic rabbit (H.E., original magnification ×25) (Source: Gomes et al. [17]).
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Figure 11. Performance of the HDDM inside the surgical bone defect after 15 days in diabetic rabbit: (a) intense osteogenic 
connective tissue showing numerous osteoblasts (asterisk) showing chemotactic activity; (b) HDDM slices in resorption 
process by osteoclasts (OC), resorbed HDDM slices (blue arrow), and HDDM slices incorporated into the newly formed 
bone tissue (black arrows) (hematoxylin-eosin, magnification ×200).
Figure 12. Radiographic image of surgical defect in the parietal bone of diabetic rabbits taken at 90 days and defect 
region completely filled with mature bone trabeculae a bone marrow (hematoxylin-eosin, magnification ×25) (Source: 
Gomes et al. [17]).
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4.2.3. Platelet-rich plasma (PRP)
Platelet-rich plasma (PRP) has been described as a source of growth factors and a potentially 
ideal scaffold for tissue engineering in regenerative medicine. PRP is an autologous prod-
uct that contains highly concentrated number of platelet in a small volume of plasma from 
whole blood by gradient density centrifugation. It is a proven source of growth factors like 
platelet-derived growth factor (PGDF) and transforming growth factor β1 and β2 (TGF-β1 and 
β2), which is obtained by sequestering and concentrating platelets by gradient density cen-
trifugation [25, 47]. This substrate is considered to ameliorate tissue regeneration due to pres-
ence of essential various cytokines and growth factors (GFs). Among them, platelet-derived 
growth factor (PDGF), transforming growth factor β1 (TGF-β1), insulin-like growth factors 
(IGF), platelet factor 4 (PF-4), fibroblast growth factor 2 (FGF-2), vascular endothelial growth 
factor (VEGF), and epidermal growth factor (EGF) are considered to be the most important. 
Subsequently, through stimulation of vascular ingrowth, macrophages arrive and start produc-
ing their own cytokines and GFs, some similar to those produced by platelets. This results in a 
new and continued local tissue repair and regrowth [40]. The cytokines and growth factors also 
Figure 13. Surgical bone defect region after 90 days in diabetic rabbit. Phases of the HDDM degradation during the bone 
remodeling process: HDDM in degradation (white arrows), exchange of HDDM by well-cellularized and immature 
bone tissue with remnants of dentin matrix (asterisk), and replacement of the preexisting HDDM by mature bone tissue 
(yellow arrows) (Schmorl’s stain, magnification ×200).
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recruit resident stem cells to the site of injury, where they are stimulated to secrete additional 
growth factors and anti-inflammatory cytokines, causing more increase in collagen and matrix 
synthesis. Furthermore, the recruited stem cells will react with the environment to differentiate 
in parenchymal cells or replace the injured tissue [32].
Some investigators have reported that platelet-rich plasma (PRP) becomes more efficient in 
tissue repair when associated with bone grafts, bioactive material scaffold, or mesenchymal 
stem cells (MSCs) which are recruited at the wound site, accelerating tissue repair. This com-
plex could exhibit a synergistic effect. PRP contains numerous proteins including PDGF (αα, 
ββ, and αβ isomers), TGF-b (β1 and β2 isomers), VEGF, angiopoietins, FGF, platelet-derived 
epidermal growth factor (PDEGF), epidermal growth factor (EGF), IGF, and fibronectin. 
When it is placed into bone surgical defect, it is quickly filled by a loose connective tissue and 
newly formed bone trabeculae in a linear arrangement. This connective tissue exhibits myx-
oid features and numerous newly formed blood vessels, showing intense angiogenic activity 
and stimulating the formation of bone marrow tissue. The myxoid tissue consisted of very 
delicate collagen fibers, numerous spindle cells, and a large amount of extracellular amor-
phous matrix (Figure 15). It is possible that the myxoid tissue and intense vascularization 
have occurred due to the preservation of bioactive angiogenic factors in the PRP, e.g., VEGF 
and angiopoietins, after its confection in laboratory [17].
Figure 14. ADDM cut into slices with frozen microtomy (a) and placed into human dental socket covering its surface 
(b). Periapical radiographs after 15 (c) and 90 days (d) post-surgery. Arrow: radiopaque image suggests remaining of 
ADDM slices (Source: Gomes et al. [10]).




The ideal implant should be composed of material that is biocompatible, affordable, and 
nondegradable. Although many materials have proven suitable, alloplastic materials are an 
attractive implant type, in particular, for the treatment of maxillofacial deformities and for 
reconstruction [7, 30]. To choose an ideal alloplastic material, first, we must identify the usage 
needs and their biological and physical properties as biocompatibility, easy of obtaining, non-
carcinogenic and nonallergenic material, few production of inflammatory response, essential 
predeterminant physical-chemical properties to tissue reconstruction and regeneration, no 
susceptible to infections, sequelae or tissue sequestrum, easy anchorage, handling and ster-
ilization without losing your characteristics and physical structure, high porosity to promote 
surrounding tissue ingrowth, similar consistency to replaced tissue, stability of contact sur-
face, and good permanence in the implanted region to allow the suitable tissue reconstruction, 
especially in large defects. Among the several types of available alloplastic materials, porous 
polyethylene (porous PTFE), hydroxyapatite, and polyurethane resin derived from castor oil 
implants have been widely indicated in literature. It is worth mentioning the efficient effects 
of the porous PTFE implant when used in hard and soft tissues. Scientific investigations have 
shown its application in partial or total ossicular replacement, restorative and esthetic rhino-
plasty, orbital implants, ear reconstructions, and augmentation or correction of craniofacial 
deformities such as temporal and mandibular regions, zygomatic arch, nose, and paranasal 
areas [7, 8]. Clinical and experimental studies have proven that the PTFE porosity aids sur-
rounding tissue invasion, triggering good adhesion, and stability of the implant in the host 
site (Figure 16). However, this material can be considered poorly biocompatible by tissues, 
especially in diabetes, due to moderate-intense infiltration of mononuclear inflammation cells 
as lymphocytes, macrophages, and foreign body-type multinucleated giant cells, especially in 
uncontrolled diabetes.
Figure 15. PRP into surgical bone defect stimulating angiogenic activity and myxoit tissue with very delicate collagen 
fibers, numerous spindle cells, and a large amount of extracellular amorphous matrix, in a period of 30 days (Source: 
Gomes et al. [17]).
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Figure 16. Porous PTFE implanted into surgical bone defect in diabetic rats after 15 days. The defect was filled by fibrous 
connective tissue with discrete infiltration of mononuclear inflammatory cells and few newly formed bone trabeculae 
(arrow). The cavities show negative images (asterisk) of the polyethylene, and the soft tissue represents the pore areas 
(hematoxylin-eosin, magnification ×200).
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As a compensatory factor, some therapeutic drugs could be used in association with allo-
plastic material, such as salmon calcitonin and verapamil. Systemic administration of salmon 
calcitonin has been widely used in patients with pathologies that affect the bone metabolism, 
including osteoporosis, osteogenesis imperfect, and Paget’s disease, because of its recognized 
ability to inhibit bone resorption [8]. For support therapy, the salmon calcitonin can be indi-
cated to treat aggressive cherubism, promoting the inhibition of multinucleated giant cell 
formation and osteoclastic activity, leading to a regressive process of the disease [16].
Regarding to the verapamil, it is used for treatment of high blood pressure, cardiac arrhyth-
mias, and pectoris angina, as well as it is often indicated for diabetic individuals. Diabetic indi-
viduals are great users of this drug. The verapamil, a potent calcium channel blocker, promotes 
the inhibition of voltage-dependent calcium channel, L-type, reducing the Ca2+ entry into the 
cells and, consequently, altering their functions. Osteoclast lineages are affected, resulting in 
the inhibition of bone resorption and, thus, favoring the new bone tissue formation.
Some researches demonstrated that the verapamil has influenced the calcium balance in the 
mineralized tissues. It changes the calcium trophic hormone action, altering the endocrine 
regulator effect in the bone turnover process, since it acts directly in the inhibition of the 
osteoclasts activity. On the other hand, the increase of intracellular calcium levels of osteoblast 
stimulates the IGF-I, IGF-II, and TGF-β production, favoring the bone tissue formation [2, 8].
In addition, implant neovascularization is essential to recruit inflammatory and progenitor 
cells, initiating the wound healing and/or leading to an exponential formation of new tissues 
[8, 17]. Thus, researches have suggested an additional bioactive material to the porous poly-
ethylene implant, as mesenchymal stem cells (MSCs) or angiogenic and mitogenic factors, so 
that they can present synergistic effects and improve the environment and, consequently, the 
development of desirable tissues in a variety of reconstructive and restorative surgeries.
5. Considerations
Considering the exponential growth trend of chronic diseases, in particular, diabetes melli-
tus, ideal bioactive biomaterials for hard and soft tissue reconstruction and regeneration have 
been a great challenge for many researchers in worldwide. To choose an ideal biomaterial to 
be implanted in diabetes, we must first know the cellular and molecular pathophysiological 
mechanisms following immeasurable damages in the tissue response against any extrinsic 
factors, including impacts or grafts. In regard to the biodynamic constraints of the repair pro-
cess, the recruitment of cells, as inflammatory and progenitors cells, and growth factors and 
cytokine production or action are largely impaired in diabetics individuals, in particular, with 
uncontrolled hyperglycemia. As undesirable results, these materials could increase the risk for 
and severity of the diabetic complications instead of favoring the tissue regeneration process.
Based on basic concepts of biomaterial, it is important to highlight that the biocompatibility, 
material storage without loss of viability, ease of obtaining the material, favorable cost and 
benefit relationship, and mainly preservation of its inductive properties must be considered 
as pivotal parameters for tissue-engineered implants which could be used in diabetes. Other 
concerns of researchers are to identify the reliable material sources that do not pose any risk 
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to the donor or to the individual that will receive the cells, and to accomplish the isolation of 
cells with high potential of expansion and proliferation.
In this regard, we discussed some property and effects of biomaterials and alloplastic materi-
als that could surely be indicated in cell therapy and tissue engineering, especially in diabetic 
individuals. As a compensative factor in diabetes, we suggested the clinical application of 
the AM and DDM in isolation or in association with other materials commonly found in the 
literature. The highly effective biological properties of these scaffolds favored the develop-
ment of impaired tissues through the restoring, maintaining, or improving tissue function, 
corroborating with the basic principles of tissue engineering. Special attention has been paid 
to AM due to rich amount of growth factor and MSCs in its mesenchymal stroma, playing a 
key role in the creation of implantable tissue. Moreover, the AM is considered a promising 
source since it is usually discarded after childbirth (in humans and animals); therefore, it 
could be used without ethical or religious troubles when collected. The use of this membrane 
in some centers can be submitted the same rules for the use of organ and tissue transplants; 
however, it is worth noting the importance to conduct strict control procedures as serological 
and microbiological screening of this membrane.
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